Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00931320

Acronym

RACHEL

Enrollment

3000

Registered

2009-07-02

Start date

2009-07-31

Completion date

2009-09-30

Last updated

2009-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemias

Keywords

Ratio improvement, LDL-C, HDL-C, Ratio of Low Density Lipoprotein Cholesterol to High Density Lipoprotein Cholesterol Improvement, High Density Lipoprotein Cholesterol

Brief summary

An observational, non-interventional, multi-centre study to provide further information on the ratio of LDL-C to HDL-C improvement after statin treatment in Korean patients group.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Subjects who are taking lipid-lowering medication after diagnosed as dyslipidaemia * Subjects who have at least made 1 visit to the outpatient clinic within previous 6 months * Subjects who have records of both LDL-C and HDL-C before & after statin treatment (at least four weeks after statin taking)

Exclusion criteria

* Subjects who are unwilling or unable to provide their examination and lab result of medical chart.

Design outcomes

Primary

Measure	Time frame
Evaluate current LDL/HDL ratio in Korean patients (between baseline & after treatment)	After Treatment : at least 4 weeks before statin taking /Baseline : no limitation.

Secondary

Measure	Time frame
Evaluate difference of LDL/HDL ratio among different statins & dosages (between baseline & after treatment)	After Treatment : at least 4 weeks before statin taking / Baseline : no limitation.

Outcome results